Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Fadrozole MeSH Descriptor Data 2026


MeSH Heading
Fadrozole
Tree Number(s)
D02.626.400
D03.383.129.308.270
Unique ID
D017316
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D017316
Scope Note
A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.
Entry Term(s)
CGS 020286A
CGS-020286A
CGS-16949A
CGS020286A
FAD 286
FAD-286
FAD286
Fadrozole Hydrochloride
Fadrozole Monohydrochloride
Pharm Action
Estrogen Antagonists
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Registry Numbers
H3988M64PU
0
H0Q44H4ECQ
Related Numbers
102676-31-3
102676-47-1
H0Q44H4ECQ
CAS Type 1 Name
Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-
Previous Indexing
Imidazoles (1988-1992)
Nitriles (1988-1992)
Public MeSH Note
1993; CGS 16949A was indexed under IMIDAZOLES & NITRILES 1988-1992; CGS 020286A was indexed under FADROZOLE 2012, and under IMIDAZOLES & IMIDAZOLES 2010-2011
History Note
1993
Date Introduced
1993/01/01
Last Updated
2016/07/01
Fadrozole Preferred
CGS-16949A Narrower
Fadrozole Hydrochloride Narrower
CGS 020286A Narrower
FAD 286 Narrower
page delivered in 0.15s